These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 2889819)

  • 1. Treatment of acromegaly with a somatostatin analog in a patient with McCune-Albright syndrome.
    Geffner ME; Nagel RA; Dietrich RB; Kaplan SA
    J Pediatr; 1987 Nov; 111(5):740-3. PubMed ID: 2889819
    [No Abstract]   [Full Text] [Related]  

  • 2. Polyostotic fibrous dysplasia with acromegaly.
    Harris RI
    Am J Med; 1985 Mar; 78(3):539-42. PubMed ID: 3976710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mammosomatotroph hyperplasia associated with acromegaly and hyperprolactinemia in a patient with the McCune-Albright syndrome. A histologic, immunocytologic and ultrastructural study of the surgically-removed adenohypophysis.
    Kovacs K; Horvath E; Thorner MO; Rogol AD
    Virchows Arch A Pathol Anat Histopathol; 1984; 403(1):77-86. PubMed ID: 6426154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. McCune-Albright syndrome and acromegaly: effects of hypothalamopituitary radiotherapy and/or pegvisomant in somatostatin analog-resistant patients.
    Galland F; Kamenicky P; Affres H; Reznik Y; Pontvert D; Le Bouc Y; Young J; Chanson P
    J Clin Endocrinol Metab; 2006 Dec; 91(12):4957-61. PubMed ID: 16984995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acromegaly and its treatment in the McCune-Albright syndrome.
    Premawardhana LD; Vora JP; Mills R; Scanlon MF
    Clin Endocrinol (Oxf); 1992 Jun; 36(6):605-8. PubMed ID: 1424186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atypical McCune-Albright syndrome associated with growth hormone-prolactin pituitary adenoma: natural history, long-term follow-up, and SMS 201-995--bromocriptine combined treatment results.
    Cremonini N; Graziano E; Chiarini V; Sforza A; Zampa GA
    J Clin Endocrinol Metab; 1992 Oct; 75(4):1166-9. PubMed ID: 1400888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Acromegaly associated with McCune-Albright syndrome].
    Tóth M; Töke J; Kiss E; Bernád I; Miheller P; Szücs N; Rácz K
    Orv Hetil; 2002 May; 143(19 Suppl):1070-3. PubMed ID: 12063863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [McCune-Albright syndrome associated with hyperthyroidism].
    Recasens A; Cabrer J; Angel M; Calderón MD; Vilardell E
    Med Clin (Barc); 1985 Feb; 84(7):277-9. PubMed ID: 3982147
    [No Abstract]   [Full Text] [Related]  

  • 9. Acromegaly and hyperthyroidism associated with McCune-Albright syndrome.
    Misaki M; Shima T; Ikoma J; Morioka K; Suzuki S
    Horm Res; 1988; 30(1):26-7. PubMed ID: 3220461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Long-term treatment of acromegaly with a somatostatin analog].
    Vest S
    Ugeskr Laeger; 1987 Aug; 149(34):2263. PubMed ID: 2897734
    [No Abstract]   [Full Text] [Related]  

  • 11. Fibrous dysplasia protuberans in a patient with McCune-Albright syndrome.
    Hamadani M; Awab A; Rashid A; Ali T; Brown B
    J Coll Physicians Surg Pak; 2006 May; 16(5):376-7. PubMed ID: 16756788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypersecretion of growth hormone and prolactin in McCune-Albright syndrome.
    Cuttler L; Jackson JA; Saeed uz-Zafar M; Levitsky LL; Mellinger RC; Frohman LA
    J Clin Endocrinol Metab; 1989 Jun; 68(6):1148-54. PubMed ID: 2498385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acromegaly, multinodular goiter and silent polyostotic fibrous dysplasia. A variant of the McCune-Albright syndrome.
    Abs R; Beckers A; Van de Vyver FL; De Schepper A; Stevenaert A; Hennen G
    J Endocrinol Invest; 1990 Sep; 13(8):671-5. PubMed ID: 2273209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Advancing acromegaly with low growth hormone levels. Influence of an analog of somatostatin administered in continuous subcutaneous infusion].
    Leblanc H; Lebouc Y; Saltiel H; Thote A; Passa P
    Presse Med; 1988 Feb; 17(4):164. PubMed ID: 2894669
    [No Abstract]   [Full Text] [Related]  

  • 15. Gigantism and hyperprolactinemia in polyostotic fibrous dysplasia (Mc Cune--Albright syndrome).
    Polychronakos C; Tsoukas G; Ducharme JR; Letarte J; Collu R
    J Endocrinol Invest; 1982; 5(5):323-6. PubMed ID: 7153476
    [No Abstract]   [Full Text] [Related]  

  • 16. Growth hormone excess and sexual precocity in polyostotic fibrous dysplasia (McCune-Albright syndrome): evidence for abnormal hypothalamic function.
    Lightner ES; Penny R; Frasier SD
    J Pediatr; 1975 Dec; 87(6 Pt 1):922-7. PubMed ID: 1185394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. McCune-Albright syndrome with acromegaly.
    Pun KK; Chan G; Kung A; Lam K; Chan FL; Wang C
    Horm Metab Res; 1989 Sep; 21(9):527-8. PubMed ID: 2583677
    [No Abstract]   [Full Text] [Related]  

  • 18. McCune-Albright syndrome and acromegaly: clinical studies and responses to treatment in five cases.
    Chanson P; Dib A; Visot A; Derome PJ
    Eur J Endocrinol; 1994 Sep; 131(3):229-34. PubMed ID: 7921205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Octreotide therapy of growth hormone excess in the McCune-Albright syndrome.
    Sherman SI; Ladenson PW
    J Endocrinol Invest; 1992 Mar; 15(3):185-90. PubMed ID: 1624678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pituitary adenoma in McCune-Albright syndrome: MR demonstration.
    O'Laughlin RL; Selinger SE; Moriarty PE
    J Comput Assist Tomogr; 1989; 13(4):685-8. PubMed ID: 2745790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.